This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (113)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Steven R. Gundry, MD; Richard E. Burney, MD; Norman W. Thompson, MD; Riccardo Lloyd, MD

Arch Surg. 1983;118(5):529-532.

Abstract
• The treatment of Hürthle cell neoplasms of the thyroid is controversial because of a lack of information about their clinical behavior and long-term follow-up. We reevaluated our experience of the past 33 years and compared our early experience with the more aggressive surgical approach used during the past ten years. We treated 62 patients with Hürthle cell neoplasm from 1949 through 1982. Twenty-six patients had benign neoplasms and 35 had malignant neoplasms proven by capsular or vascular invasion or nodal metastasis. Fourteen deaths were directly attributable to recurrent or metastatic disease, three among those with benign lesions. An aggressive surgical approach, involving total thyroidectomy or earlycompletion total thyroidectomy following lobectomy for all tumors histologically malignant or larger than 2cm, resulted in a lower recurrence rate (21% v 59%) and fewer operations per patient (1.7 v 2.9) than in patients having other operations.

(Arch Surg 1983;118:529-532)

Author Affiliations
From the Division of Endocrine Surgery, Section of General Surgery (Drs Gundry, Burney, and Thompson), and the Department of Pathology (Dr Lloyd), University of Michigan, Ann Arbor.

Footnotes
Accepted for publication Jan 20, 1983.

Read before the 90th annual meeting of the Western Surgical Association, Kansas City, Mo, Nov 16, 1982.

Reprint requests to South Ambulatory Care Bldg, D2227, University of Michigan Hospitals, Ann Arbor, MI 48109 (Dr Thompson).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

My approach to oncocytic tumours of the thyroid
Asa
J. Clin. Pathol. 2004;57:225-232.
ABSTRACT | FULL TEXT  

Chromosomal Aberrations by Comparative Genomic Hybridization in Hurthle Cell Thyroid Carcinomas Are Associated with Tumor Recurrence
Wada et al.
J. Clin. Endocrinol. Metab. 2002;87:4595-4601.
ABSTRACT | FULL TEXT  

Hurthle Cell Carcinoma: A Critical Histopathologic Appraisal
Stojadinovic et al.
JCO 2001;19:2616-2625.
ABSTRACT | FULL TEXT  

Flow Cytometric Measurements of Nuclear DNA and Ploidy Analysis in Hurthle Cell Neoplasms of the Thyroid
McLeod et al.
Arch Surg 1988;123:849-854.
ABSTRACT  

DNA Flow Cytometry of Thyroid Neoplasms
Kraemer et al.
Arch Otolaryngol Head Neck Surg 1985;111:34-38.
ABSTRACT  

Radionuclide Thyroid Angiography and Surgical Correlation: A Five-Year Study
Moe et al.
Arch Otolaryngol Head Neck Surg 1984;110:717-720.
ABSTRACT  

Hurthle Cell Tumors of the Thyroid Gland: A Clinicopathologic Review and Long-term Follow-up
Caplan et al.
JAMA 1984;251:3114-3117.
ABSTRACT  

Hurthle Cell Neoplasms: Malignant Potential
Gosain and Clark
Arch Surg 1984;119:515-519.
ABSTRACT  

Treatment of Hurthle Cell Neoplasms of the Thyroid
BONDESON et al.
Arch Surg 1983;118:1453-1453.
ABSTRACT